SCHEMBL2807916

SCHEMBL2807916

OCCc1ccc(Nc2ncc3c(n2)-c2ccccc2C(c2ccc(Cl)cc2Cl)C3)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 2/20 0.47
FGFR2 P21802 2/20 0.47
FGFR3 P22607 2/20 0.47
CSF1R P07333 1/20 0.47
CCNA2 P20248 1/20 0.45
CDK2 P24941 1/20 0.45
KDR P35968 10/20 0.44
CDK1 P06493 6/20 0.44
PLK1 P53350 4/20 0.44
EGFR P00533 3/20 0.43
ABL1 P00519 2/20 0.43
SRC P12931 2/20 0.43
PDGFRA P16234 2/20 0.43
PDGFRB P09619 1/20 0.43
MAPK14 Q16539 1/20 0.43
AURKA O14965 2/20 0.43
AXL P30530 2/20 0.41
BMPR1B O00238 1/20 0.41
PLK4 O00444 1/20 0.41
PDPK1 O15530 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2806618 0.93 FGFR1 (0.48) FGFR1FGFR2FGFR3CSF1RCCNA2
SCHEMBL2805594 0.93 FGFR1 (0.48) FGFR1FGFR2FGFR3CSF1RCCNA2
SCHEMBL2802728 0.89 CCNA2 (0.48) FGFR1FGFR2FGFR3CSF1RCCNA2
SCHEMBL2802789 0.89 CCNA2 (0.48) FGFR1FGFR2FGFR3CSF1RCCNA2
SCHEMBL2489914 0.89 CCNA2 (0.48) FGFR1FGFR2FGFR3CSF1RCCNA2
SCHEMBL13273567 0.87 CDK1 (0.49) FGFR1FGFR2FGFR3CSF1RCCNA2
SCHEMBL2489995 0.87 FGFR1 (0.45) FGFR1FGFR2FGFR3CSF1RCCNA2
SCHEMBL2491788 0.87 FGFR1 (0.45) FGFR1FGFR2FGFR3CSF1RCCNA2
SCHEMBL2806802 0.87 FGFR1 (0.45) FGFR1FGFR2FGFR3CSF1RCCNA2
Hydrochloric Acid SCHEMBL2488981 0.87 CDK1 (0.49) FGFR1FGFR2FGFR3CSF1RCCNA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2379506-B1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE INC (US) 2015-09-02 EP disclosed
EP-2379506-B1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE INC (US) 2015-09-02 EP disclosed
US-8357694-B2 Substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds ARQULE, INC. (US) 2013-01-22 US disclosed
US-8357694-B2 Substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds ARQULE, INC. (US) 2013-01-22 US disclosed
US-8357694-B2 Substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds ARQULE, INC. (US) 2013-01-22 US disclosed
US-20100239525-A1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE, INC. (US) 2010-09-23 US disclosed
WO-2010078421-A1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F] ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE, INC. (US) 2010-07-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100239525-A1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS NQO1, DPYD, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 FGFR1 530/4885FGFR2 511/4885FGFR3 521/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.